Lantern Pharma Inc. (LTRN) insider trading
Over the last 12 months, 2 insiders bought $200K and 0 insiders sold $0 of Lantern Pharma Inc. stock on the open market, according to SEC Form 4 filings.
Latest insider buys and sells
- May 12, 2026: Keyser D Jeffrey bought 48,544 shares ($100K)
- May 12, 2026: Schalop Lee Troy bought 48,544 shares ($100K)
- Jun 13, 2025: Cavu Management, LP sold 40,000 shares ($124K)
- Jun 13, 2025: BIOS Fund I, LP sold 40,000 shares ($124K)
- Jun 12, 2025: Cavu Management, LP sold 61,613 shares ($208K)
- Jun 12, 2025: BIOS Fund I, LP sold 61,613 shares ($208K)
- May 29, 2025: Cavu Management, LP sold 56,237 shares ($168K)
- May 29, 2025: BIOS Fund I, LP sold 56,237 shares ($168K)